Boothwyn Pharmacy LLC recalls Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Recalled September 10, 2025 · FDA recall D-0608-2025 · Boothwyn Pharmacy
Hazard
Subpotent Drug · FDA Class II
Units
186 vials
Sold at
U.S. Nationwide
Description
Subpotent Drug
Product
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Manufacturer(s)
Boothwyn Pharmacy LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →